A detailed history of Trust Investment Advisors transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Trust Investment Advisors holds 11,580 shares of EW stock, worth $1.09 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
11,580
Previous 11,601 0.18%
Holding current value
$1.09 Million
Previous $884,000 25.11%
% of portfolio
0.81%
Previous 0.7%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$72.54 - $95.56 $1,523 - $2,006
-21 Reduced 0.18%
11,580 $1.11 Million
Q4 2023

Jan 31, 2024

BUY
$61.71 - $77.76 $863 - $1,088
14 Added 0.12%
11,601 $884,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $16,350 - $22,037
-236 Reduced 2.0%
11,587 $802,000
Q2 2023

Aug 10, 2023

BUY
$81.41 - $94.33 $37,692 - $43,674
463 Added 4.08%
11,823 $1.12 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $6,163 - $7,014
-83 Reduced 0.73%
11,360 $939,000
Q4 2022

Feb 28, 2023

BUY
$68.3 - $87.44 $781,556 - $1 Million
11,443 New
11,443 $853,000
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $5,683 - $7,403
-69 Reduced 0.57%
12,022 $993,000
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $121,100 - $179,578
-1,400 Reduced 10.38%
12,091 $1.15 Million
Q1 2022

May 02, 2022

BUY
$101.96 - $128.34 $2,956 - $3,721
29 Added 0.22%
13,491 $1.59 Million
Q4 2021

Feb 02, 2022

SELL
$106.37 - $130.68 $10,637 - $13,068
-100 Reduced 0.74%
13,462 $1.74 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $26,962 - $32,160
-262 Reduced 1.9%
13,562 $1.54 Million
Q2 2021

Jul 23, 2021

BUY
$83.84 - $104.76 $61,454 - $76,789
733 Added 5.6%
13,824 $1.43 Million
Q1 2021

May 06, 2021

SELL
$78.68 - $90.67 $44,926 - $51,772
-571 Reduced 4.18%
13,091 $1.1 Million
Q4 2020

Feb 05, 2021

SELL
$71.69 - $91.23 $22,438 - $28,554
-313 Reduced 2.24%
13,662 $1.25 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $5,039 - $6,558
75 Added 0.54%
13,975 $1.12 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $535,697 - $716,404
9,310 Added 202.83%
13,900 $961,000
Q1 2020

Apr 30, 2020

SELL
$52.41 - $81.0 $7,861 - $12,150
-150 Reduced 3.16%
4,590 $866,000
Q4 2019

Feb 03, 2020

SELL
$71.7 - $82.09 $1,792 - $2,052
-25 Reduced 0.52%
4,740 $1.11 Million
Q2 2019

Jul 30, 2019

SELL
$55.74 - $64.41 $39,018 - $45,087
-700 Reduced 12.81%
4,765 $880,000
Q1 2019

May 03, 2019

SELL
$47.89 - $64.05 $43,101 - $57,645
-900 Reduced 14.14%
5,465 $1.05 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $9,140 - $11,606
200 Added 3.24%
6,365 $1.11 Million
Q2 2018

Aug 03, 2018

BUY
$42.45 - $51.3 $4,245 - $5,130
100 Added 1.65%
6,165 $897,000
Q1 2018

May 29, 2018

SELL
$37.19 - $47.45 $14,876 - $18,980
-400 Reduced 6.19%
6,065 $846,000
Q4 2017

Feb 09, 2018

BUY
$33.79 - $39.39 $2,027 - $2,363
60 Added 0.94%
6,465 $729,000
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $232,437 - $248,706
6,405
6,405 $700,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $58B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Trust Investment Advisors Portfolio

Follow Trust Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Trust Investment Advisors with notifications on news.